Hi, what are you looking for?
Jewish Business News
Search results for " Teva Pharmaceutical"
Business
The exercising of the underwriters' options brings the total raised by Teva Pharmaceuticals in its current offering to $7.24 billion.
Business
Teva Pharmaceutical Industries Ltd has announced today two offerings totaling approximately $6.75 billion of ordinary and preferred shares to fund its takeover of Allergan Plc’s...
Life science
Pfizer will hold a 10% stake in the Israeli company, as part of its acquisition of Allergan.
Business
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) announced today that the the Japanese Ministry of Health, Labour and Welfare has approved once-daily...
Business
Gecko has developed a cloud-based solution to simplify chronic respiratory disease management through remote monitoring.
Business
The acquisition gives Teva exclusive rights to Immuneering's cutting-edge analytics to advance treatments for diseases of the CNS.
Business
Teva CFO Eyal Desheh: We appreciate the strong support we received which stems from the compelling economics of this transaction
Business
Teva bought its 4.6% stake in Mylan at prices of $69-74 per share. the share price is down sharply in premarket trading.
Business
The deal, the largest ever acquisition by an Israeli company, is in cash and shares.
Mergers & Acquisitions
Teva will pay over $45 billion for the botox maker unit, report the "Wall Street Journal."